Publicaciones (31) Publicaciones de GINESA MARIA GARCIA ROSTAN PEREZ

2018

  1. The phosphatidic acid phosphatase lipin-1 facilitates inflammation-driven colon carcinogenesis

    JCI Insight, Vol. 3, Núm. 18

2016

  1. A new role of the Rac-GAP β2-chimaerin in cell adhesion reveals opposite functions in breast cancer initiation and tumor progression

    Oncotarget, Vol. 7, Núm. 19, pp. 28301-28319

2015

  1. Anaplastic Thyroid Carcinoma: Molecular Tools for Diagnosis and Therapy

    International Journal of Endocrinology

2013

  1. CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model

    Oncogene, Vol. 32, Núm. 22, pp. 2726-2738

2012

  1. FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma

    Endocrine-Related Cancer, Vol. 19, Núm. 5, pp. 695-710

2011

  1. Poorly differentiated thyroid carcinoma: An evolving entity

    Diagnostic Histopathology, Vol. 17, Núm. 3, pp. 114-123

  2. TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype

    Journal of Clinical Endocrinology and Metabolism, Vol. 96, Núm. 5

2008

  1. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma

    Clinical Endocrinology, Vol. 68, Núm. 4, pp. 618-634

2007

  1. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in Northern Spain: Mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations

    Journal of Clinical Endocrinology and Metabolism, Vol. 92, Núm. 12, pp. 4853-4864

  2. Paragangliomas de cabeza y cuello: Revisión de 89 casos en 73 pacientes

    Acta Otorrinolaringologica Espanola, Vol. 58, Núm. 3, pp. 94-100

2005

  1. Hürthle (oncocytic) cell tumors of thyroid: Etiopathogenesis, diagnosis and clinical significance

    International Journal of Surgical Pathology, Vol. 13, Núm. 1, pp. 29-35

  2. Mitogenic effects of the up-regulation of minichromosome maintenance proteins in anaplastic thyroid carcinoma

    Journal of Clinical Endocrinology and Metabolism, Vol. 90, Núm. 8, pp. 4703-4709

  3. Mutation of the PIK3CA gene in anaplastic thyroid cancer

    Cancer Research, Vol. 65, Núm. 22, pp. 10199-10207

2003

  1. ras Mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer

    Journal of Clinical Oncology, Vol. 21, Núm. 17, pp. 3226-3235

2002

  1. Abnormalities of the APC/β-catenin pathway in endometrial cancer

    Oncogene, Vol. 21, Núm. 52, pp. 7981-7990

  2. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: A search for the early precursors of papillary cancer

    American Journal of Pathology, Vol. 160, Núm. 6, pp. 2157-2167

  3. RET activation and clinicopathologic features in poorly differentiated thyroid tumors

    Journal of Clinical Endocrinology and Metabolism, Vol. 87, Núm. 1, pp. 370-379

2001

  1. β-catenin dysregulation in thyroid neoplasms: Down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis

    American Journal of Pathology, Vol. 158, Núm. 3, pp. 987-996

1999

  1. Downregulation of p27(KIP1) and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories

    American Journal of Surgical Pathology, Vol. 23, Núm. 6, pp. 678-685

  2. Frequent chromosomal DNA unbalance in thyroid oncocytic (Hurthle cell) neoplasms detected by comparative genomic hybridization

    Laboratory Investigation, Vol. 79, Núm. 5, pp. 547-555